List of Excipients in API dextromethorphan hydrobromide and quinidine sulfate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dextromethorphan hydrobromide and quinidine sulfate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Avanir Pharmaceuticals Inc | NUEDEXTA | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 | CELLULOSE, MICROCRYSTALLINE | |
| Avanir Pharmaceuticals Inc | NUEDEXTA | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 | CROSCARMELLOSE SODIUM | |
| Avanir Pharmaceuticals Inc | NUEDEXTA | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 | LACTOSE MONOHYDRATE | |
| Avanir Pharmaceuticals Inc | NUEDEXTA | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 | MAGNESIUM STEARATE | |
| Avanir Pharmaceuticals Inc | NUEDEXTA | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 | SILICON DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing dextromethorphan hydrobromide and quinidine sulfate
Detailed excipient profiles for dextromethorphan hydrobromide and quinidine sulfate
Excipient focus: AMMONIA
dextromethorphan hydrobromide and quinidine sulfate drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 31722-693 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide and quinidine sulfate drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Avanir Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
dextromethorphan hydrobromide and quinidine sulfate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Avanir Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide and quinidine sulfate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 31722-693 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
dextromethorphan hydrobromide and quinidine sulfate drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 31722-693 |
| Avanir Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide and quinidine sulfate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
dextromethorphan hydrobromide and quinidine sulfate drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 31722-693 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide and quinidine sulfate drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Avanir Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
dextromethorphan hydrobromide and quinidine sulfate drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 31722-693 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide and quinidine sulfate drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Avanir Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
dextromethorphan hydrobromide and quinidine sulfate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 31722-693 |
| Avanir Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide and quinidine sulfate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
dextromethorphan hydrobromide and quinidine sulfate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 31722-693 |
| Avanir Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide and quinidine sulfate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
dextromethorphan hydrobromide and quinidine sulfate drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 31722-693 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide and quinidine sulfate drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Avanir Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
dextromethorphan hydrobromide and quinidine sulfate drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 31722-693 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide and quinidine sulfate drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Avanir Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
dextromethorphan hydrobromide and quinidine sulfate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 31722-693 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide and quinidine sulfate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Avanir Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
dextromethorphan hydrobromide and quinidine sulfate drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 31722-693 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide and quinidine sulfate drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Avanir Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
dextromethorphan hydrobromide and quinidine sulfate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 31722-693 |
| Avanir Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide and quinidine sulfate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
dextromethorphan hydrobromide and quinidine sulfate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 31722-693 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide and quinidine sulfate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Avanir Pharmaceuticals Inc | dextromethorphan hydrobromide and quinidine sulfate | 64597-301 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
